Alnylam Pharmaceuticals
ALNY | NASDAQ
$159.73
-$5.31 (-3.22%)
At close: Nov 16, 2026, 4:00 PM ET
$160.20
+$0.47 (+0.29%)
After-hours:
Nov 16, 2026, 7:51 PM ET
Alnylam Pharmaceuticals Statistics
Key statistics explainedMarket Data
$21.39B
$19.07B
0.27
1.87M
138.04M
0.5%
N/A
NASDAQ
US02043Q1076
Price Performance
-31.1%
-28.9%
-44.2%
-59.8%
-65.3%
-2.4%
-7.5%
-31.1%
-64.4%
-0.9%
13.6%
Valuation
8.07
8.96
0.00
0.01
4.27
3.30
5.94
42.73
110.73
33.91
3.80
15.99
15.28
38.08
12.4%
2.3%
0.9%
Financial Health
$2.57B
$1.26B
$3.59B
$7.99B
2.48
2.43
0.35
1.01
2.52
0.52
2.68
3.87
4
Margins & Profitability
77.3%
19.5%
24.9%
54.3%
10.0%
3.9%
6.1%
-61.4%
Returns
34.1%
159.7%
15.4%
16.5%
34.1%
Historical Growth (CAGR)
42.7%
46.3%
63.3%
193.1%
904.8%
59.8%
98.5%
3203.5%
39.3%
Analyst Forecasts
Buy
24
-15.3%
20.3%
Feb 11, 2027
$1.72
109.8%
$1.53B
39.0%
Fair Value Estimates
$107.85
-32.5%
$495.00
209.9%
$322.00
101.6%
Cash Flow
$650.37M
$500.73M
$193.2M
$3.63
$4.71
13.0%
Income Statement
$5.01B
$3.87B
$977.59M
$1.25B
$2.72B
$19.80
$2.01M
$1.09M
2,500
Add to Watchlist
Select watchlists to add or remove ALNY